Tonix Pharmaceuticals Holding
Corp. (OTCBB:TNXP) is a specialty pharmaceutical company developing
therapies for challenging disorders of the central nervous system, including
fibromyalgia syndrome and post-traumatic stress disorder.
The company will be presenting at two conferences this month in San
Francisco. On Monday, January 9, 2012 at 10:00 a.m. PST, TONIX will present at
the Biotech Showcase
2012, and on Tuesday, January 10, 2012 at 10:15 a.m. PST, TONIX will present
at the OneMedForum
Conference.
At each presentation, Seth Lederman,
M.D., Chairman and President of TONIX, will provide an overview of the
company and discuss its clinical development and business strategy. Both
presentations will be webcast, and can be accessed at the following links:
OneMed Forum: www.onemedplace.com
Biotech Showcase: http://www.media-server.com/m/p/422u9mik
Members of the investment community who are interested in meeting with
management during the week of January 9 in San Francisco are encouraged to call
Sharon Weinstein at 212-564-4700 to schedule a meeting.